United Therapeutics (UTHR) Total Liabilities (2009 - 2026)
United Therapeutics (UTHR) posted Total Liabilities of $813.1 million for Q1 2026, up 3.74% sequentially from $783.8 million in Q4 2025, and down 13.2% YoY from $936.7 million in Q1 2025.
United Therapeutics (UTHR) Total Liabilities (2009 - 2026) Analysis & Trends
United Therapeutics has reported Total Liabilities for 18 years, with the latest figure at $813.1 million in Q1 2026.
- Quarterly Total Liabilities fell 13.2% year-over-year to $813.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $813.1 million (down 13.2% YoY) and the FY2025 annual result came in at $783.8 million, down 14.8% from the prior year.
- Total Liabilities advanced to $813.1 million in Q1 2026 per UTHR's latest filing, from $783.8 million in the prior quarter.
- Over five years, Total Liabilities peaked at $1.3 billion in Q3 2023 and troughed at $734.4 million in Q2 2025.
- A 5-year average of $1.1 billion and a median of $1.2 billion in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Liabilities climbed 7.55% in 2023, then decreased 28.42% in 2025.
- Over 5 years, Total Liabilities stood at $1.2 billion in 2022, then slipped by 5.26% to $1.2 billion in 2023, then retreated by 22.18% to $920.0 million in 2024, then slipped by 14.8% to $783.8 million in 2025, then increased by 3.74% to $813.1 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $813.1 million, $783.8 million, and $760.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 2.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 819.80 Mn |
| Mar 31, 2026 | 813.10 Mn |
| Dec 31, 2025 | 783.80 Mn |
| Sep 30, 2025 | 760.90 Mn |
| Jun 30, 2025 | 734.40 Mn |
| Mar 31, 2025 | 936.70 Mn |
| Dec 31, 2024 | 920.00 Mn |
| Sep 30, 2024 | 1.02 Bn |
| Jun 30, 2024 | 1.03 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.18 Bn |
| Sep 30, 2023 | 1.31 Bn |
| Jun 30, 2023 | 1.27 Bn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.25 Bn |
| Sep 30, 2022 | 1.22 Bn |
| Jun 30, 2022 | 1.22 Bn |
| Mar 31, 2022 | 1.18 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Sep 30, 2021 | 1.22 Bn |